Navigation Links
Scientists discover previously unidentified gene key to melanoma progression

San Francisco, CA (PRWEB) February 25, 2015

The mainstay of targeted therapy for melanoma, BRAF inhibitors, has significantly improved the survival of patients with advanced stages of the illness. But resistance to therapy develops in most patients, causing them to stop therapy or switch to another agent. Multiple mechanisms have been proposed that may govern resistance to BRAF inhibitors.

However, whether patients can continue to benefit from targeted therapies has been unclear—until now, with findings uncovered about the previously unidentified gene bromodomain PHD finger transcription factor (BPTF), and its role in tumor development and resistance to therapy. The study was published online today in the Journal of the National Cancer Institute.

“This is the first evidence of the potent role played by BPTF in promoting tumor progression, and of its potential as a molecular diagnostic and prognostic marker,” said Mohammed Kashani-Sabet, MD, Director of the California Pacific Medical Center (CPMC) Center for Melanoma Research and Treatment, Senior Scientist at CPMC’s Research Institute, and senior author of the study.

In the study, Dr. Kashani-Sabet and colleagues at CPMC and the Veterans Affairs Medical Center explored the functional and biological significance of BPTF—known to be important to the remodeling of genetic material and in the developing brain.

The researchers used RNA interference to block the effects of BPTF in several melanoma cells lines, and then assessed the effects on key measures of cancer growth and metastasis. The gene’s functional role was investigated using an animal model of melanoma progression, and tissues from melanoma patients were examined for BPTF’s role as a prognostic biomarker. Levels of the gene were analyzed in tumor samples from eight patients with metastatic melanoma before and after therapy with two commonly used BRAF-inhibitors, vemurafenib and dabrafenib.

Results showed that silencing BPTF significantly suppressed the proliferative capacity and metastatic potential of melanoma cells by two thirds. Suppressing BPTF increased the cells’ sensitivity to BRAF inhibitors, whereas overexpression of BPTF promoted resistance to these drugs. Elevated BPTF copy number was observed in 28 of 77 (36.4%) melanomas. In a cohort of 311 melanoma patients, BPTF over-expression predicted poor survival (distant metastasis-free survival, p=0.03, and disease-specific survival p=0.008), and promoted resistance to BRAF inhibitors in melanoma cell lines.

“Surprisingly, when we examined the tumors of patients who had progressed on anti-BRAF therapy, they were composed of two groups of cells: those that showed no BPTF expression (indicating response to therapy), while other clones of cells had high BPTF expression (suggesting BRAF-resistant cells),” said Dr. Kashani-Sabet, noting the novel finding of intra-tumor molecular heterogeneity. “In contrast, examining tumors from these patients before treatment showed uniform expression of BPTF.”

“Our results suggest that treatment with selective BRAF inhibitors may potentially be continued following the development of resistance, as part of combination therapy. In addition, BPTF-targeting may be a new approach to overcome resistance to BRAF inhibitors, including possible combination treatment for BRAF-mutant melanoma.”

This year alone, more than 76,000 people will be diagnosed with melanoma in the U.S.

The study was supported by United States Public Health Service Grants and by the Mary R. and Joseph R. Payden Foundation.

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Scientists at Cancer Prevention Institute of California Find That a Diet High in Fruits and Vegetables May Significantly Reduce Risk of Breast Cancer
2. Volunteers join scientists in finding out who gets rid of cow dung
3. A*STAR scientists uncover potential drug target to nip cancer in the bud
4. CNIO scientists decipher how the immune system induces liver damage during hepatitis
5. NSF International Scientists Announce Discovery of New Bacterium, Same Family as E. coli and Klebsiella Pneumonia
6. A*STAR scientists bring to light mechanism of drug for infections
7. Scientists fingerprint single cancer cells to map cancers family tree
8. Renowned Scientists Join Cure Alzheimer’s Fund’s Search for Alzheimer’s Therapies
9. LSUHSC faculty shares inside knowledge in book to develop nations research scientists
10. Scientists far from finish line in understanding anemia in female athletes
11. Scientists show how cells protect their DNA from catastrophic damage
Post Your Comments:
(Date:10/15/2019)... , ... October 15, 2019 , ... In 2019, Unitek ... to shut down in late 2018 . Students who started in July were ... it seemed as if these students would have to start over. Then the leadership ...
(Date:10/11/2019)... ... ... Inland Detox, Inc. has just moved to a new location in the ... Temecula Valley and it’s the perfect place for long-term residential alcohol and substance ... well as double occupancy rooms, a 2nd home where all treatment takes place, a ...
(Date:10/10/2019)... SAN MATEO, Calif. (PRWEB) , ... October 10, 2019 , ... ... 2019 Senior Living Report on the Best and Worst Places for Seniors to Live. ... housing options, community engagement, transportation, quality of life and workforce development. , According ...
(Date:10/8/2019)... ... October 08, 2019 , ... SoCal Adolescent Wellness announces the opening of ... expansion of our services to better serve the families in Orange County," said Becca ... to see the extraordinary impact this pre-intervention program has on the lives of the ...
(Date:10/8/2019)... ... October 08, 2019 , ... Drs. Joel Rosenlicht ... with missing teeth restore their smiles with long-lasting dental implants . Placing ... advanced i-CAT® 3D Cone Beam CT imaging, X-Guide™ software and Yomi® robotic-assisted technology ...
Breaking Medicine News(10 mins):
(Date:10/11/2019)... ... ... Based on data for the first eight months of the year, 2019 ... 2018. Through August 31, 7,786 deceased donors have provided 23,797 organs for transplant according ... pace, the Association of Organ Procurement Organizations (AOPO) projects 2019 could see an additional ...
(Date:10/10/2019)... , ... October 10, 2019 , ... ... Gala Cocktail Reception on Thursday, September 26, at the Westchester Country Club in ... the unwavering support of the organization and its mission. , “In Celebration” featured ...
(Date:10/8/2019)... ... 09, 2019 , ... “When Seconds Count: Reports From an Emergency Medical Helicopter ... HEMS world through telling the real stories of the EMS flight crew. “When Seconds ... Jay A. Humphrey, an EMS helicopter pilot. He has been a pilot in the ...
Breaking Medicine Technology: